Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00085345 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Stage II Multiple Myeloma
Stage III Multiple Myeloma
Refractory Plasma Cell Neoplasm

Interventions

DRUG: arsenic trioxide
DRUG: ascorbic acid
DRUG: melphalan
PROCEDURE: chemosensitization/potentiation
PROCEDURE: chemotherapy

Sponsor

Oncotherapeutics